PD-1

Open Access
PD-1⁺Tim-3⁺CD103⁺ CD8⁺ Tumor-infiltrating Lymphocytes Are Associated With Favorable Outcomes in Colorectal Cancer
DAIJIRO MATOBA, TAKURO SAITO, TAKEHIRO NODA, MAMORU UEMURA, AZUMI UEYAMA, HISASHI WADA, YUICHIRO DOKI and HIDETOSHI EGUCHI

Anticancer Research May 2026, 46 (5) 2387-2401; DOI: https://doi.org/10.21873/anticanres.18125
Open Access
P53-armed Oncolytic Adenovirus Enhances the Efficacy of PD-1 Blockade in Neuroblastoma by Inducing Immunogenic Cell Death
MORIMICHI TANI, HIROSHI TAZAWA, TERUTAKA TANIMOTO, HIROSHI NOUSO, HINAKO WATANABE, TAKANORI OYAMA, YASUO URATA, SHUNSUKE KAGAWA, TAKUO NODA, SHINJI KURODA and TOSHIYOSHI FUJIWARA

Anticancer Research April 2026, 46 (4) 1769-1784; DOI: https://doi.org/10.21873/anticanres.18073
You have access
Immunohistochemical Expression and Clinicopathological Assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 Expression in Desmoid Tumor
KAZUHIKO HASHIMOTO, SHUNJI NISHIMURA, HIROKI TAN, TOMOHIKO ITO and KOJI GOTO

Anticancer Research March 2026, 46 (3) 1411-1419; DOI: https://doi.org/10.21873/anticanres.18037
You have access
Neoadjuvant Chemoradiotherapy Enhances Tumor PD-L1 Expression in Pancreatic Cancer
KANECHIKA DEN, TAKASHI MURAKAMI, RYUSEI MATSUYAMA, KENTARO MIYAKE, YUKI HOMMA, YASUHIRO YABUSHITA, RYUTARO MORI, YUKIHIKO HIROSHIMA, IKUMA KATO and ITARU ENDO

Anticancer Research April 2025, 45 (4) 1731-1747; DOI: https://doi.org/10.21873/anticanres.17554
Open Access
Peripheral CD4⁺ T Cells Predict T Cell Immunity in Lung Tissues of Non-small Cell Lung Cancer Patients
MARI TONE, TOMOMI ISONO, YOKO YAMAMOTO, YOSHITO TAKEDA, YASUSHI SHINTANI, ATSUSHI KUMANOGOH, HISASHI WADA and KOTA IWAHORI

Anticancer Research March 2025, 45 (3) 909-920; DOI: https://doi.org/10.21873/anticanres.17478
You have access
Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
YOUNG WHA KOH, JAE-HO HAN, SEOKJIN HAAM and HYUN WOO LEE

Anticancer Research May 2024, 44 (5) 2081-2089; DOI: https://doi.org/10.21873/anticanres.17012
Open Access
Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab
NAOTO WAKITA, NOBUYUKI HINATA, YUKARI BANDO, TAKUTO HARA, TOMOAKI TERAKAWA, JUNYA FURUKAWA, YUZO NAKANO and MASATO FUJISAWA

Anticancer Research February 2023, 43 (2) 841-847; DOI: https://doi.org/10.21873/anticanres.16226
You have access
Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis
CHIERI NAKAYAMA, KIYONORI TANOUE, TETSUYA IDICHI, HIROKI SHIMOMURA, YOSHIAKI KITA, YUTO HOZAKA, YOSHIAKI SHINDEN, DAISUKE MATSUSHITA, AKIHIRO NAKAJO, TAKAAKI ARIGAMI, YUKO MATAKI, HIROSHI KURAHARA and TAKAO OHTSUKA

Anticancer Research July 2022, 42 (7) 3373-3380; DOI: https://doi.org/10.21873/anticanres.15824
Open Access
Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial Cancer
THOMAS HECKING, THORE THIESLER, JANINA HALBE, LUCIA OTTEN, FLORIAN RECKER, HEIDRUN GEVENSLEBEN, TIM MÜLLER, CYNTHIA SCHILLER, EVA K. EGGER, ROLF FIMMERS, MATTHIAS B. STOPE, GLEN KRISTIANSEN and ALEXANDER MUSTEA

Anticancer Research March 2022, 42 (3) 1367-1376; DOI: https://doi.org/10.21873/anticanres.15606
You have access
The Expression of Immune Checkpoint Receptors and Ligands in the Colorectal Cancer Tumor Microenvironment
PRAJWAL NEUPANE, KOSAKU MIMURA, SHOTARO NAKAJIMA, HIROKAZU OKAYAMA, MISATO ITO, AUNG KYI THAR MIN, KATSUHARU SAITO, HISASHI ONOZAWA, SHOTARO FUJITA, WATARU SAKAMOTO, MOTONOBU SAITO, ZENICHIRO SAZE, TOMOYUKI MOMMA and KOJI KONO

Anticancer Research October 2021, 41 (10) 4895-4905; DOI: https://doi.org/10.21873/anticanres.15303

Main menu

User menu

Search

PD-1

Pages